Cullinan Therapeutics
Todd Shearer is an experienced biopharmaceutical executive currently serving as Vice President at Cullinan Therapeutics since June 2023. Previously, Todd held the position of Vice President and Senior Director of Clinical Pharmacology at SpringWorks Therapeutics, contributing to the development of treatments for rare diseases and cancer from January 2019 to June 2023. Todd's extensive background includes serving as Executive Director of Nonclinical and Clinical Pharmacology at Nuventra Pharma Sciences and Director of Drug Metabolism and Pharmacokinetics at GlaxoSmithKline. With a strong foundation in drug development and pharmacology, Todd's career commenced in the US Army as a Captain and Biochemist. Todd holds a PhD in Molecular and Cellular Biology, an MS in Environmental Studies, and a BS in Biology.
This person is not in the org chart
This person is not in any teams
Cullinan Therapeutics
1 followers
Cullinan Therapeutics is dedicated to creating new standards of care for patients. We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class. Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.